Disclaimer: EMA by AIVF has CE mark. In the US, an AI component of EMA is considered an investigational device. Limited by Federal (or United States) law to investigational use.
©All rights reserved AIVF 2023
About top About top mobile

Technology with

AIVF is leading the next generation of IVF. We are on a mission to help patients, clinics and labs achieve the best IVF outcomes by developing advanced AI solutions. Our AI solutions pioneer the convergence of digitization and automation in the IVF clinic to help patients on a smoother, quicker and more accessible path to parenthood.
Background pink

Our Story
By fertility experts, for fertility experts

Our journey began with Daniella Gilboa, a clinical embryologist, working on her PhD thesis. Using complex data sets to solve problems, she realized the huge potential for data to transform IVF. Daniella founded AIVF, together with Prof. Daniel Seidman, a reproductive medicine expert, to develop advanced technology to help remove the barriers to successful IVF – financial, accessibility and uncertainty.

Today, AIVF holds CE Mark for its novel EMA software platform, and is GDPR and HIPAA compliant. Join us as we embark on this remarkable journey leading the next generation of fertility care using the power of AI and innovation.




Team members

Join us

Take a look at the career options at AIVF
Background pink 2

Increase accessibility to IVF
treatments with AI

Daniella Gilboa,
CEO and Co-Founder

Our Leadership

Daniella Gilboa

and CEO

Prof. Daniel Seidman

and Chief Medical Officer

Amir Sarig

Chief Financial Officer

Eyal Veitzman

Chief Operations Officer

Ron Maor


Eyal Ohayon

VP Engineering

Yariv Zur

VP Product

Scientific Advisory Board

Marcos Meseguer, PhD

Scientific Supervisor and
Senior Embryologist
IVIRMA Valencia

Nikica Zaninovic, PhD

Embryology Lab Director and
Associate Professor
Weill Cornell Medicine

Gary Harton, PhD

Chief Scientific Officer and
Vice Chair, ASRM PGT
Special Interest Group